Crossmark

Interleukin-17 inhibitors in myasthenia gravis: really bad or maybe good?

Crossref DOI link: https://doi.org/10.1007/s10072-023-06796-8

Published Online: 2023-04-11

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Sohyeon

Eun, Mi-Yeon

Seok, Hung Youl https://orcid.org/0000-0002-9938-5355
License Information

Text and Data Mining valid from 2023-04-11

Version of Record valid from 2023-04-11
More Information

Article History

Received: 19 March 2023

Accepted: 5 April 2023

First Online: 11 April 2023

Declarations

:

: None.

: The authors declare no competing interests.